Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inovio Pharma (NQ: INO ) 5.550 -0.100 (-1.77%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Inovio Pharma < Previous 1 2 3 4 5 6 7 8 9 Next > Inovio Pharma Releases Favorable Data From Booster DNA Vaccine Candidate For Ebola February 02, 2023 Inovio Pharmaceuticals Inc (NASDAQ: INO) announced results from a Phase 1b trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a... Via Benzinga 3 Sorry Pharma Stocks to Sell in February Before It’s Too Late February 01, 2023 These are the pharma stocks to sell, as they represent companies with weak fundamentals and sustained cash burn visibility. Via InvestorPlace INOVIO Announces Further Reorganization, Continues Focus on Promising DNA Candidates January 31, 2023 Via Benzinga If You Invested $1,000 In Inovio Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now January 10, 2023 Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two and a half years. But there was no question some big-name stocks performed... Via Benzinga Futu Holdings, UP Fintech Holding And Some Other Big Stocks Moving Lower On Friday December 30, 2022 U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Friday. Here are some big stocks recording losses in today’s session. Via Benzinga Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript November 08, 2022 INO earnings call for the period ending September 30, 2022. Via The Motley Fool Why Inovio Pharmaceuticals' Shares Jumped 17.31% on Monday October 17, 2022 The stock jumped Monday despite no news from the company. Via The Motley Fool Inovio Pharma Highlights Early Data From Experimental Drug For Respiratory Tract Disease October 13, 2022 Via Benzinga Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session December 22, 2022 U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. Westrock Coffee Company, LLC (NASDAQ: WEST) shares tumbled 10.9% to $11.90... Via Benzinga Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket December 20, 2022 Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small... Via Benzinga Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket December 19, 2022 Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in... Via Benzinga Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs November 18, 2022 Via Benzinga 3 Stocks to Avoid Right Now November 17, 2022 Even though many stocks have fallen sharply in price, not all are bargains -- investors must remains selective. Via The Motley Fool While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants November 16, 2022 EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END Via FinancialNewsMedia Exposures COVID-19 Why Inovio Pharmaceuticals Stock Is Popping Off November 09, 2022 Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher by 9.11% to $2.34 after the company reported third-quarter financi Via Benzinga What's Going On With Inovio Pharmaceuticals Stock Tuesday After Hours November 08, 2022 Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading marginally lower by 0.93% to $2.12 after the company reported Via Benzinga Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa November 03, 2022 Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases... Via Benzinga Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today October 28, 2022 The biotech is ceasing its internally funded efforts to develop a heterologous coronavirus booster. Via The Motley Fool Inovio Pharma Stops Work On INO-4800 As COVID-19 Heterologous Booster October 28, 2022 Via Benzinga Philips, Owens & Minor And Some Other Big Stocks Moving Lower In Today's Pre-Market Session October 12, 2022 U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 November 01, 2022 Upgrades Via Benzinga Tesla, Credit Suisse And Some Other Big Stocks Moving Lower In Today's Pre-Market Session October 03, 2022 U.S. stock futures traded mixed this morning after recording losses for the third quarter. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday October 18, 2022 Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case. Via Benzinga Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed August 26, 2022 Via Benzinga Recap: Inovio Pharmaceuticals Q2 Earnings August 09, 2022 Inovio Pharmaceuticals (NASDAQ:INO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Via Benzinga Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful August 09, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Two Appealing Biotech Stocks for Two Distinct investors August 08, 2022 Investing in biotech stocks carries both risk and reward. This article highlights two biotech companies that may appeal to specific investing styles Via MarketBeat Topics Intellectual Property Exposures COVID-19 Intellectual Property Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday August 11, 2022 Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. Via Benzinga Does Amarin Deserve a Spot in Your Portfolio after Earnings ? August 04, 2022 Amarin recently announced its earnings for Q2'22 with mixed results. Here we'll examine the pros and cons of having this penny stock in your portfolio. Via MarketBeat Topics Earnings Exposures Financial Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak August 01, 2022 The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.